Towards the development of a pediatric ventricular assist device.
The very limited options available to treat ventricular failure in children with congenital and acquired heart diseases have motivated the development of a pediatric ventricular assist device at the University of Pittsburgh (UoP) and University of Pittsburgh Medical Center (UPMC). Our effort involves a consortium consisting of UoP, Children's Hospital of Pittsburgh (CHP), Carnegie Mellon University, World Heart Corporation, and LaunchPoint Technologies, Inc. The overall aim of our program is to develop a highly reliable, biocompatible ventricular assist device (VAD) for chronic support (6 months) of the unique and high-risk population of children between 3 and 15 kg (patients from birth to 2 years of age). The innovative pediatric ventricular assist device we are developing is based on a miniature mixed flow turbodynamic pump featuring magnetic levitation, to assure minimal blood trauma and risk of thrombosis. This review article discusses the limitations of current pediatric cardiac assist treatment options and the work to date by our consortium toward the development of a pediatric VAD.
Borovetz
Harvey S
HS
Department of Bioengineering & McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. borovetzhs@upmc.edu
Badylak
Stephen
S
Boston
J Robert
JR
Johnson
Carl
C
Kormos
Robert
R
Kameneva
Marina V
MV
Simaan
Marwan
M
Snyder
Trevor A
TA
Tsukui
Hiro
H
Wagner
William R
WR
Woolley
Joshua
J
Antaki
James
J
Diao
Chenguang
C
Vandenberghe
Stijn
S
Keller
Bradley
B
Morell
Victor
V
Wearden
Peter
P
Webber
Steven
S
Gardiner
Jeff
J
Li
Chung M
CM
Paden
Dave
D
Paden
Bradley
B
Snyder
Shaun
S
Wu
Jingchun
J
Bearnson
Gill
G
Hawkins
John A
JA
Jacobs
Gordon
G
Kirk
John
J
Khanwilkar
Pratap
P
Kouretas
Peter C
PC
Long
James
J
Shaddy
R E
RE
D001672:Biocompatible Materials; D002648:Child; D015199:Extracorporeal Membrane Oxygenation; D006353:Heart-Assist Devices; D006801:Humans
D001672:Biocompatible Materials